Edition:
United States

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

130.00EUR
2 Dec 2016
Change (% chg)

€-0.45 (-0.34%)
Prev Close
€130.45
Open
€130.50
Day's High
€130.50
Day's Low
€129.35
Volume
21,107
Avg. Vol
31,382
52-wk High
€143.20
52-wk Low
€97.17

Select another date:

Thu, Nov 10 2016

BRIEF-Biomerieux launches system for extraction of DNA and RNA

* Launches EMAG, a new generation automated system for extraction of DNA and RNA

BRIEF-Biomerieux 9 months sales up at 1.51 billion euros

* 9 months sales of 1.51 billion euros versus 1.41 billion euros ($1.55 billion) a year ago

BRIEF-Biomerieux' Filmarray Respiratory Panel EZ is CLIA waived by the FDA

* Filmarray Respiratory Panel EZ (RP EZ) is clia waived by the FDA

BRIEF-Biomerieux introduces Evisight Compact

* Biomerieux introduces Evisight Compact, a new automated diagnostic solution for microbial detection in pharmaceutical production Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

BRIEF-Biomerieux 2016 guidance revised to top of range

* H1 net income of consolidated companies 86 million euros ($95.9 million) versus 59 million euros a year ago

BRIEF-Biomerieux H1 sales up 10.9 pct, at constant exchange rates and scope of consolidation

* Strong growth in sales, up 10.9 pct, at constant exchange rates and scope of consolidation in first half of 2016

BRIEF-Biomerieux reports Q2 growth in sales of 10.9 pct

* Q2 strong growth in sales, up 10.9 pct, at constant exchange rates and scope of consolidation in first half of 2016

BRIEF-Biomerieux gets FDA clearance for VIDAS B.R.A.H.M.S PCT test

* Biomerieux receives FDA clearance for expanded use of VIDAS B.R.A.H.M.S PCT test for managing sepsis patients with elevated risk of mortality Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Select another date: